Antiviral Therapy

Aims & Scope

Antiviral Therapy (an official publication of the International Society of Antiviral Research) is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases.

Antiviral Therapy is one of the leading journals in virology and infectious diseases.

The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy.

It features editorials, original research papers, specially commissioned review articles, letters and book reviews.

The journal is aimed at physicians and specialists interested in clinical and basic research.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,800.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Silver Nanoparticles Inhibit Hepatitis B virus Replication

  Citation: 503

  Authors: Lei, Raymond Wai-Yin, Rong, Chee-Kin, Chi-Ming, John M, George KK, Chi-Ming

• Challenges of Convalescent Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre Experience

  Citation: 261

  Authors: Jae-Hoon, Hyeri, Sun Young, Young Eun, Jin Yang, So Hyun, Yae-Jean, Jin Kyeong, Chi Ryang, Eun-Suk, Duck, Marcel A, Christian, Cheol-In, Doo Ryeon, Jae-Hoon, Kyong Ran

• Human Coronaviruses: What Do They Cause?

  Citation: 256

  Authors: Lia

• The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan

  Citation: 253

  Authors: Victor, Lynn, Richard, Dan, Andrew, Mounir, John, Philippe, Scott, Richard, David, Randall, Michael, Michael, Sabine, Andrew, Jeffrey, Amy, Veronica, Steven, Louise, John

• Selection of Hepatitis B Virus Polymerase Mutations in HIV-Coinfected Patients Treated with Tenofovir

  Citation: 229

  Authors: Julie, Nuria, Berta, Angeline, Michael, Frank, Marina, Stefan, Thomas, Gerd, Stephen, Vincent

• Susceptibility of HIV-2, Siv and Shiv to Various Anti-HIV-1 Compounds: Implications for Treatment and Postexposure Prophylaxis

  Citation: 224

  Authors: Myriam, Christophe, William M, Thomas M, Erik De, Walid

• Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment

  Citation: 211

  Authors: Diane E, Mark, Silvia, Donald, Charles F

• <i>In vitro</i> Selection and Characterization of HIV-1 with Reduced Susceptibility to PMPA

  Citation: 210

  Authors: Mark A, Michael D, Yudong, Horacio, Andrew S, Patrick D, Nicolas A, Kristin E, Julie M

• Long-Term Lamivudine Therapy Reduces the Risk of Long-Term Complications of Chronic Hepatitis B Infection even in Patients without Advanced Disease

  Citation: 209

  Authors: Man-Fung, Wai-Kay, Danny Hoi-Fan, Kit, Danny Ka-Ho, Vincent Wing-Shun, Benjamin Chun-Yu, James, John Chi-Hang, Ching-Lung

• Management of Antiviral Resistance in Patients with Chronic Hepatitis B

  Citation: 192

  Authors: Stephen, Angelos, Jenny, Emmet B, T Jake, David, Jean-Michel, Fabien